Proprotein convertase subtilisin/kexin type 9 (PCSK9): PCSK9 can irreversibly bind to LDL receptors, elevating its levels [150] and increasing the risk of atherosclerosis and cardiovascular events [151]. Here, PCSK9 is linked to atherosclerosis.